Discordant MRI/FDG- PET imaging for the diagnosis of borderline ovarian tumors. Issue 4 (1st July 2008)

• Record Type: Journal Article
• Authors: Jung, D. C.; Choi, H. J.; Ju, W.; Kim, S. C.; Choi, K-G.
• Is Part Of: International journal of gynecological cancer. Volume 18:Issue 4(2008)
• Page Start: 637
• Page End: 641
• Publication Date: 2008-07-01
• Subjects: borderline ovarian tumor -- MRI -- PET; Generative organs, Female -- Cancer -- Periodicals; 616.99465
• DOI: 10.1136/ijgc-00009577-200807000-00006
• Languages: English
• ISSNs: 1048-891X

Abstract

Abstract : The objective of this study was to assess the role of 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) for the characterization of ovarian masses that were diagnosed as ovarian malignancies by magnetic resonance imaging (MRI). We performed a retrospective review of eight patients with pathologically confirmed borderline ovarian tumors (BOT) who underwent MRI and FDG-PET before surgical staging from August 2005 to March 2007. We assessed the PET imaging of the BOT, measured the FDG uptake and quantified the findings as a standardized uptake value (SUV). The FDG-PET scans, of all eight patients, showed uptake of FDG with a mean SUV of less than 2.0 in the solid portion of the masses evaluated. We conclude that the MRI–PET differences may help differentiate borderline from malignant ovarian tumors.